You searched for Antibody candidate - Page 11 of 67

Best in Biotech 18 Dec 2017

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

…results. Its candidate, ABX464, caused a significant reduction of viral reservoirs over a 28-day period. The study included just 11 patients, with 9 completing the study and 8 of those…

December 18, 2017 - 9 minutesmins - By Alex Dale

In Depth 16 Jul 2025

Eight rare autoimmune diseases biotechs are fighting to treat

…two candidates for Graves’ disease: batoclimab and IMVT-1402. In September 2024, the company reported positive phase 2a results from a clinical trial investigating the monoclonal antibody batoclimab in patients with…

July 16, 2025 - 12 minutesmins - By Willow Shah-Neville

Best in Biotech 7 Mar 2024

6 biotech companies tackling antibiotic resistance

…a pipeline of immune-enabling therapies and vaccines for life-threatening bacterial infections associated with biofilms, with a near-term focus on challenging respiratory infections. Clarametyx’s lead candidate is an immune-enabling antibody therapy…

March 7, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 30 Nov 2023

Could an Alzheimer’s vaccine make treatment more affordable?

…Reuters report, AC Immune is challenging this rhetoric. The Swiss company’s phase 1/2 ABATE trial is testing its Alzheimer’s vaccine candidate ACI-24.060 in patients with Down’s syndrome. The candidate is…

November 30, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 28 May 2025

New weight loss drugs: Biotech’s mission to end obesity

…Viking’s candidate appeared to have “outmaneuvered” amycretin. Biopharma giant Amgen is also seeing positive results for its most advanced obesity asset MariTide, a monoclonal antibody linked to a pair of…

May 28, 2025 - 17 minutesmins - By Willow Shah-Neville

cancer cell screening drug discovery microplate

News and Trends 7 Oct 2022

GATC AI platform reduces time to find opioid use disorder candidates

…candidates’ safety and efficacy in reducing opioid consumption, withdrawal symptoms and relapse. To discover these specific drug candidates for OUD, GATC obtained addiction drug target biomarkers from Liquid Biosciences, an…

October 7, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

…candidates are engineered T cells designed to express the Tmod receptors, enabling them to differentiate between cancerous and non-cancerous cells. This selective targeting aims to reduce off-target effects and improve…

June 13, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 11 Apr 2024

Seven companies leading the mRNA revolution in biotechnology

…2 results from last week revealed that the seasonal flu vaccine candidate boosted antibody titers at all dose levels and for all encoded seasonal influenza strains across younger and older…

April 11, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Mar 2024

Are these T cell receptor (TCR) therapy companies on your radar?

…and allogeneic candidates as well as antibody-like TCR bispecifics, called T cell Engaging Receptors (TCER). TCERs are biologics that are designed to bind T cells to target and destroy cancer…

March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 8 Nov 2017

Phase I Results are in for Swedish Biotech’s Cancer Antibody

…develops antibody-based immunotherapies to fight cancer. Its pipeline includes clinical and pre-clinical drug candidates, including ADC-1013 and ATOR-1015, as well as novel research candidates. The company has announced that its…

November 8, 2017 - 3 minutesmins - By Alex Dale

News and Trends 20 Dec 2019

CureVac and Genmab Team up to Make Antibody Cancer Drugs out of RNA

…could be circumvented by delivering simple mRNA blueprints for antibody drugs into the patient, and turning the patient’s own cells into antibody factories. There are challenges to overcome on the…

December 20, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 4 Nov 2024

Top biotech deals of October 2024

…arteries restricts blood supply to leg muscles. While financial terms weren’t revealed, the candidate they plan to advance was disclosed. ISM-001 is an antibody designed to neutralize an antibody that…

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Eight rare autoimmune diseases biotechs are fighting to treat

6 biotech companies tackling antibiotic resistance

Could an Alzheimer’s vaccine make treatment more affordable?

New weight loss drugs: Biotech’s mission to end obesity

GATC AI platform reduces time to find opioid use disorder candidates

Eight companies tackling cancer with allogeneic cell therapy in 2024

Seven companies leading the mRNA revolution in biotechnology

Are these T cell receptor (TCR) therapy companies on your radar?

Phase I Results are in for Swedish Biotech’s Cancer Antibody

CureVac and Genmab Team up to Make Antibody Cancer Drugs out of RNA

Top biotech deals of October 2024

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!